Uterine Leiomyoma (Uterine Fibroids) - Market Insights, Epidemiology and Market Forecast - 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 70
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Uterine Leiomyoma (Uterine Fibroids) - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Uterine Leiomyoma (Uterine Fibroids) for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Uterine Leiomyoma (Uterine Fibroids) . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Uterine Leiomyoma (Uterine Fibroids) for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Uterine Leiomyoma (Uterine Fibroids) market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Uterine Leiomyoma (Uterine Fibroids) , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Uterine Leiomyoma (Uterine Fibroids) for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Uterine Leiomyoma (Uterine Fibroids) 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Uterine Leiomyoma (Uterine Fibroids) market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

  • Understanding historical and forecasted epidemiological data for Uterine Leiomyoma (Uterine Fibroids) covering 7MM from 2015-2025.

  • Segment level epidemiology and market split for Uterine Leiomyoma (Uterine Fibroids) .

  • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Uterine Leiomyoma (Uterine Fibroids) .

  • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Uterine Leiomyoma (Uterine Fibroids) market trends.

  • Thorough market distribution based on market share for Uterine Leiomyoma (Uterine Fibroids) .

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Uterine Leiomyoma (Uterine Fibroids) market.

  • To understand the future market competition in the Uterine Leiomyoma (Uterine Fibroids) market and Insightful review of the key market drivers and barriers.

  • Organize sales and marketing efforts by identifying the best opportunities for Uterine Leiomyoma (Uterine Fibroids) in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

  • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

Uterine Leiomyoma (Uterine Fibroids) - Market Insights, Epidemiology and Market Forecast - 2025

Table of Contents

1. Report Introduction

2. Uterine Leiomyoma (Uterine Fibroids) Market Overview at a Glance
2.1. Total Market Share Distribution of Uterine Leiomyoma (Uterine Fibroids) for 7 MM in 2016
2.2. Total Market Share Distribution of Uterine Leiomyoma (Uterine Fibroids) for 7 MM in 2025

3. Uterine Leiomyoma (Uterine Fibroids)
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment

4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Uterine Leiomyoma (Uterine Fibroids) in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Uterine Leiomyoma (Uterine Fibroids) in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Uterine Leiomyoma (Uterine Fibroids) in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Uterine Leiomyoma (Uterine Fibroids) in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Uterine Leiomyoma (Uterine Fibroids) in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Uterine Leiomyoma (Uterine Fibroids) in United Kingdom

5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices

6. Marketed Drugs for Uterine Leiomyoma (Uterine Fibroids)
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status

7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase

8. Overview of Total Uterine Leiomyoma (Uterine Fibroids) Market (2016 & 2025)

9. Uterine Leiomyoma (Uterine Fibroids) : Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)

10. Market Drivers

11. Market Restraints

12. Appendix

13. Report Methodology

14. Consulting Services

15. Disclaimer

16. About DelveInsight

List of Tables

Table 1: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in United States (2015-2025)
Table 2: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in Germany (2015-2025)
Table 3: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in France (2015-2025)
Table 4: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in Spain (2015-2025)
Table 6: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in Italy (2015-2025)
Table 7: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in Japan (2015-2025)
Table 8: List of Marketed Drugs for Uterine Leiomyoma (Uterine Fibroids)
Table 9: List of Pipeline Phase III Drugs for Uterine Leiomyoma (Uterine Fibroids)
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Table 17: Germany Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Table 18: France Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Table 20: Spain Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Table 21: Italy Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Table 22: Japan Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)

List of Figures

Figure 1: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in United States (2015-2025)
Figure 2: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in Germany (2015-2025)
Figure 3: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in France (2015-2025)
Figure 4: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in United Kingdom (2015-2025)
Figure 5: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in Spain (2015-2025)
Figure 6: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in Italy (2015-2025)
Figure 7: Diagnosed Cases Uterine Leiomyoma (Uterine Fibroids) in Japan (2015-2025)
Figure 8: List of Marketed Drugs for Uterine Leiomyoma (Uterine Fibroids)
Figure 9: List of Pipeline Phase III Drugs for Uterine Leiomyoma (Uterine Fibroids)
Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
Figure 11: Clinical Trials by Trial status, 2017
Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
Figure 13: Clinical Trials by Trial status, 2017
Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
Figure 15: Clinical Trials by Trial status, 2017
Figure 16: United States Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Figure 17: Germany Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Figure 18: France Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Figure 19: United Kingdom Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Figure 20: Spain Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Figure 21: Italy Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
Figure 22: Japan Market Size of Uterine Leiomyoma (Uterine Fibroids) in USD, Million (2015-2025)
  • Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 46
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2017, provides an overview of the Female Hypoactive Sexual Desire Disorder (Women's Health) pipeline landscape.Hypoactive sexual desire disorder (HSDD) is an absence of sexual fantasies and desire for sexual activity. The predisposing factors include anxiety, depression, androgen deficiencies, and chronic debilitating illnesses, such as chronic ren......
  • Premenstrual Syndrome - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Premenstrual Syndrome - Pipeline Review, H2 2017, provides an overview of the Premenstrual Syndrome (Women's Health) pipeline landscape.Premenstrual syndrome (PMS) is a collection of physical and emotional symptoms related to a woman's menstrual cycle. Premenstrual syndrome has a wide variety of symptoms, including mood swings, tender breasts, food cravings, fatigue, irritability and depression.Repo......
  • Women Infertility - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 187
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H2 2017, provides an overview of the Women Infertility (Women's Health) pipeline landscape.Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due to damage of fallopian tubes, ovulation disorders (polycystic ovary syndrome) and endometriosis. Symptoms include abnormal periods, weight gain, back pain, pelvic pain, and cram......
  • Global Bacterial Vaginosis Drug Market Professional Survey Report 2017
    Published: 09-Oct-2017        Price: US 3500 Onwards        Pages: 113
    This report studies Bacterial Vaginosis Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Bayer - Pfizer - Sanofi - Piramal - Abbott - ......
  • Global Postmenopausal Vaginal Atrophy Treatment Market Research Report 2011-2023
    Published: 03-Oct-2017        Price: US 1940 Onwards        Pages: 85
    Summary Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase. The global Postmenopausal Vaginal Atrophy Treatment market will reach xxx Mill......
  • Global Menopause Partnering 2010-2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Menopause Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understan......
  • Global Contraception Partnering 2010-2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Contraception Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides under......
  • Global Obstetrics Partnering 2010-2017: Deal trends, players and financials
    Published: 01-Oct-2017        Price: US 2995 Onwards        Pages: 200
    "Delivery of this report will take 1-3 days after purchase." Global Obstetrics Partnering 2010 to 2017 provides the full collection of Obstetrics disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Obstetrics partnering deals Financial deal terms for headline, upfront and royalty by stage of development Obstetrics partnering agreement structure Obstetrics partnering contract ......
  • Global Gynecology Partnering 2010-2017: Deal trends, players and financials
    Published: 01-Oct-2017        Price: US 2995 Onwards        Pages: 300
    "Delivery of this report will take 1-3 days after purchase." Global Gynecology Partnering 2010-2017: Deal trends, players and financials provides the full collection of Gynecology disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Gynecology partnering deals Financial deal terms for headline, upfront and royalty by stage of development Gynecology partnering agreement structure......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs